arrow_back Back Filing freshness 40-F FY 2025 SEC EDGAR

Curaleaf Holdings, Inc.

CURLF
Price unavailable
Materials ·Medicinal Chemicals & Botanical Products ·USMedicinal Chemicals & Botanical Products
7 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
30
Health
Poor
Bearish
auto_awesome

Analytical Summary

Curaleaf Holdings, Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap
Dividend Yield
Revenue Growth -5.6%
Op. Margin 2.0%
ROIC 5.0%
FCF / Share $0.10
Trailing P/E
Price / Book
FCF Yield
Debt / Equity 0.73
info Valuation on last close.

7-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.27B
↓ -5.6%
Net Income Profit after all expenses
$-231.07M
↓ -7.3%
Operating Margin Operating profit as % of sales
2.0%
↑ +33.4% 33th
FCF / Share Free cash flow per share
$0.10
↑ +4.0%
Long-Term Debt Long-term obligations
$548.65M
↓ -3.5%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
31
Returns
23
Financial Health
45
Cash Quality
15

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 7 quarters